Peter Blumbergs

This inventor holds 19 USPTO granted patents and 1 published patent application and 7 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Pharmion Corporation, Ash Stevens, Inc., Celgene Corporation. Active years: 1986-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter Blumbergs. Retrieved from https://idiyas.com/inventor/peter-blumbergs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 (Patent Applications = 1)

% Patents Active = 78.9

EPO Patents = 7 (Patent Applications = 6)

Average Co-Inventor Count = 2.5

ph-index = 9

Forward Citations = 238(Granted Patents)

Location History:

Ann Arbor, MI (US) (2010)
Royal Oak, MI (US) (1986 - 2015)

Company Filing History:

Dana-Farber-Cancer Institute Inc.

patents

5. 1 out of 8,753

US Government as Represented by the Secretary of the Army

patents

where one patent can have more than one assignee

Years Active: 1986-2015

Loading Chart...

Areas of Expertise:

5-Azacytidine

Pharmaceutical Compositions

Crystalline Forms

Synthesis

Ornithine Derivatives

Ammonium Salts

Isolation Methods

Hydrogenation

Active Ingredients

Preparation Processes

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9192620 - Pharmaceutical compositions comprising forms of 5-azacytidine (2015-11-24),

2. 8975392 - Methods for isolating crystalline form I of 5-azacytidine (2015-03-10),

3. 8779117 - Pharmaceutical compositions comprising 5-azacytidine monohydrate (2014-07-15),

4. 8614313 - Pharmaceutical compositions comprising forms of 5-azacytidine (2013-12-24),

5. 8513406 - Pharmaceutical compositions comprising forms of 5-azacytidine (2013-08-20),

6. 8481715 - Methods for isolating crystalline form I of 5-azacytidine (2013-07-09),

7. 8211862 - Pharmaceutical compositions comprising crystal forms of 5-azacytidine (2012-07-03),

8. 8058424 - Synthesis of 5-azacytidine (2011-11-15),

9. 7858774 - Synthesis of 5-azacytidine (2010-12-28),

10. 7772199 - Forms of 5-azacytidine (2010-08-10),

11. 7700770 - Methods for isolating crystalline form I of 5-azacytidine (2010-04-20),

12. 7078518 - Forms of 5-Azacytidine (2006-07-18),

13. 7038038 - Synthesis of 5-azacytidine (2006-05-02),

14. 6989386 - Pharmaceutically active ornithine derivatives, ammonium salts thereof and methods of making same (2006-01-24),

15. 6943249 - Methods for isolating crystalline Form I of 5-azacytidine (2005-09-13),

Title: An Insight into the Innovative Work of Peter Blumbergs

Introduction

Peter Blumbergs, an esteemed inventor hailing from Royal Oak, MI, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 19 patents, he has played a critical role in advancing medicinal chemistry and drug formulations.

Latest Patents

Among his notable inventions are two latest patents focusing on 5-azacytidine. The first patent presents novel polymorphic and pseudopolymorphic crystalline forms of 5-azacytidine, along with methods for preparing these forms. This invention aims to enhance the efficacy and stability of pharmaceutical compositions containing 5-azacytidine. The second patent outlines methods for isolating crystalline Form I of 5-azacytidine, ensuring its purity for further pharmaceutical applications. These innovations are poised to break new ground in the application of 5-azacytidine in therapeutic treatments.

Career Highlights

Throughout his career, Peter has been associated with prominent companies in the pharmaceutical sector, including Pharmion Corporation and Ash Stevens, Inc. His work in these organizations has allowed him to develop and refine his expertise, leading to his prolific output of patents in the field.

Collaborations

Collaborating with skilled professionals has also been a hallmark of Peter's career. He has worked alongside notable colleagues, such as Dumitru Ionescu and Gary Lee Silvey, contributing to a diverse range of projects aimed at enhancing pharmaceutical innovation.

Conclusion

Peter Blumbergs exemplifies the spirit of innovation in the pharmaceutical industry. His advancements in the formulations of 5-azacytidine not only highlight his dedication as an inventor but also underscore the importance of collaboration in achieving groundbreaking discoveries. With 19 patents to his name, Peter continues to pave the way for future advancements in medicine.

Profile summary based on public USPTO records.